Literature DB >> 19709705

Estimating the burden of disease and the economic cost attributable to chikungunya, Andhra Pradesh, India, 2005-2006.

T Seyler1, Y Hutin, V Ramanchandran, R Ramakrishnan, P Manickam, M Murhekar.   

Abstract

To estimate the burden and cost of chikungunya in India, we searched for cases of fever and joint pain in the village of Mallela, Andhra Pradesh, and collected information on the demography, signs, symptoms, healthcare utilization and expenditure associated with the disease. We estimated the burden of the disease using disability-adjusted life years (DALYs). We estimated direct and indirect costs and made projections for the district and state using surveillance data corrected for under-reporting. On average, from December 2005 to April 2006, each of the 242 cases in the village led to a burden of 0.0272 DALYs (95% CI 0.0224-0.0319) and a cost of US$37.50 (95% CI 30.6-44.3). Overall, chikungunya in Mallela led to 6.57 DALYs and a loss of US$9100. Out-of-pocket direct medical costs accounted for 68% of the total. From January to December 2006 the burden for Kadapa district was 160 DALYs (cost: US$290 000). Over the same period the burden for Andhra Pradesh was 6600 DALYs (cost: US$12 400 000). While the burden was moderate, costs were high and mostly out of pocket. Copyright 2009 Royal Society of Tropical Medicine and Hygiene. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 19709705     DOI: 10.1016/j.trstmh.2009.07.014

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  23 in total

1.  Total economic cost and burden of dengue in Nicaragua: 1996-2010.

Authors:  Zachary S Wettstein; Michael Fleming; Aileen Y Chang; David J Copenhaver; Angela R Wateska; Sarah M Bartsch; Bruce Y Lee; Rajan P Kulkarni
Journal:  Am J Trop Med Hyg       Date:  2012-08-13       Impact factor: 2.345

2.  Development of a stable virus-like particle vaccine formulation against Chikungunya virus and investigation of the effects of polyanions.

Authors:  Ryan M Kramer; Yuhong Zeng; Neha Sahni; Lisa A Kueltzo; Richard M Schwartz; Indresh K Srivastava; Lindsey Crane; Sangeeta B Joshi; David B Volkin; C Russell Middaugh
Journal:  J Pharm Sci       Date:  2013-10-15       Impact factor: 3.534

Review 3.  Insights into Antibody-Mediated Alphavirus Immunity and Vaccine Development Landscape.

Authors:  Anthony Torres-Ruesta; Rhonda Sin-Ling Chee; Lisa F P Ng
Journal:  Microorganisms       Date:  2021-04-22

4.  Seven years of the field epidemiology training programme (FETP) at Chennai, Tamil Nadu, India: an internal evaluation.

Authors:  Tarun Bhatnagar; Mohan D Gupte; Yvan J Hutin; Prabhdeep Kaur; Vasanthapuram Kumaraswami; Ponnaiah Manickam; Manoj Murhekar; Vidya Ramachandran; Ramachandran Ramakrishnan
Journal:  Hum Resour Health       Date:  2012-09-27

5.  Measuring the burden of arboviral diseases: the spectrum of morbidity and mortality from four prevalent infections.

Authors:  A Desirée Labeaud; Fatima Bashir; Charles H King
Journal:  Popul Health Metr       Date:  2011-01-10

6.  Seroprevalence and distribution of arboviral infections among rural Kenyan adults: a cross-sectional study.

Authors:  Luke E Mease; Rodney L Coldren; Lillian A Musila; Trish Prosser; Fredrick Ogolla; Victor O Ofula; Randal J Schoepp; Cindy A Rossi; Nicholas Adungo
Journal:  Virol J       Date:  2011-07-27       Impact factor: 4.099

7.  The Chikungunya epidemic on La Réunion Island in 2005-2006: a cost-of-illness study.

Authors:  Man-Koumba Soumahoro; Pierre-Yves Boelle; Bernard-Alex Gaüzere; Kokuvi Atsou; Camille Pelat; Bruno Lambert; Guy La Ruche; Marc Gastellu-Etchegorry; Philippe Renault; Marianne Sarazin; Yazdan Yazdanpanah; Antoine Flahault; Denis Malvy; Thomas Hanslik
Journal:  PLoS Negl Trop Dis       Date:  2011-06-14

Review 8.  Chikungunya Virus Vaccines: Platforms, Progress, and Challenges.

Authors:  Victor R DeFilippis
Journal:  Curr Top Microbiol Immunol       Date:  2022       Impact factor: 4.291

Review 9.  De-Coding the Contributions of the Viral RNAs to Alphaviral Pathogenesis.

Authors:  Autumn T LaPointe; Kevin J Sokoloski
Journal:  Pathogens       Date:  2021-06-19

10.  Evaluating the effectiveness of localized control strategies to curtail chikungunya.

Authors:  Martial L Ndeffo-Mbah; David P Durham; Laura A Skrip; Elaine O Nsoesie; John S Brownstein; Durland Fish; Alison P Galvani
Journal:  Sci Rep       Date:  2016-04-05       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.